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Prevalence of type 2 diabetes in pregnancy  
The occurrence of type two diabetes mellitus (T2DM) in pregnancy is a relatively new 
phenomenon. In previous generations women of childbearing age were considered low risk 
because until recently, T2DM was a condition related the older people in the general 
population (Diabetes UK, 2011). However, this situation has changed significantly with 
increasing numbers of younger people diagnosed with T2DM, including an estimated 1.5% 
of children with diabetes now thought to have T2DM whereas prior to 2002 T2DM was 
unknown in children (Diabetes UK, 2012). Recent reports have highlighted the growing 
prevalence of T2DM in pregnancy. The CEMACH report, (2007) found that 27% of pregnant 
women with pre-existing diabetes had T2DM. This rise reflects the increasing prevalence of 
obesity in pregnancy as increased adipose tissue is associated with increased insulin 
resistance (Diabetes UK, 2011). Heslehurst et al (2010) found that first trimester obesity had 
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more than doubled, increasing from 7.6% to 15.6% within 19 years. Likewise, a study in 
Liverpool found that 17% of women booking in for antenatal care were obese (BMI ≥ 30 
kg/m2) (Abayomi et al, 2009). 
 
Type 2 diabetes and the importance of pre-conceptual care  
Women with pre-existing T2DM require advice and support either from the primary health 
care team or referral to a dedicated diabetes multidisciplinary team (MDT) when planning a 
pregnancy. Good glycaemic control at the time of conception and in early pregnancy is 
crucial in reducing the risk of diabetes related complications (NICE, 2008). Despite this the 
CEMACH report found that only one third of women with T2DM had accessed pre-
conceptual care. 
 
CEMACH (2007) also found that less than a fifth (17%) of maternity clinics offered a 
structured, maternity multidisciplinary service. According to the medical records reviewed 
within the report, less than half of women were taking folic acid supplements, with a minority 
taking the correct dose of one 5 milligram tablet per day. Folic acid supplementation was 
lower for women with T2DM (29% compared to 43% T1DM). Moreover, less than half of 
women had been advised about glycaemic control, contraception, complications, diet and 
alcohol prior to pregnancy. Two thirds of women (79%) had suboptimal glycaemic control 
prior to conception and only 54% had HbA1c recorded in the 12 months prior to pregnancy. 
 
A number of recommendations were made to improve pre-conception care, in particular, 
ensuring that all women with diabetes have access to all members of the specialist MDT. As 
a minimum this should include an obstetrician, a diabetes physician, a diabetes specialist 
nurse, diabetes specialist midwife and dietitian (CEMACH, 2007; Department of Health (DH), 
2001). In 2012, Diabetes UK published a list of ‘15 essentials’ regarding diabetes care. One 
of these essentials (13) is access to specialist care when pregnant or planning pregnancy 
(Diabetes UK, 2012).  
 
   Primary Care 
Women should be advised by the primary health care team to access pre-conceptual care 
with their diabetes specialist nurse to achieve an HbA1c of 6.1% or lower before conception 
(NICE 2008). Moreover, individual health advice should be aimed at planning a pregnancy 
when the optimal blood glucose levels and other health related goals have been achieved. 
Pre-conceptually advice should ideally be discussed at every opportunity with the primary 
health care team (Table 1).  
 Table 1: Pre-conceptual Care 
Monthly HbA1c monitoring 
Blood glucose <5.6 millimole/litre before meals or < 7.8 millimole/litre 2 hours after eating 
Discuss the importance of a healthy balanced diet  
Avoid alcohol whilst trying to get pregnant and during pregnancy 
Stop smoking by referral to smoking cessation services  
Avoid illicit/recreational drug use by referral to the appropriate support services 
Start Folic Acid supplementation of 5 milligrams/day (higher than the recommended dose for 
the general population) before conception and up to 12 weeks gestation 
Check blood pressure 
Review existing medication as some commonly used in T2DM are contraindicated in 
pregnancy (e.g.) angiotensin-converting enzyme (ACE) inhibitors or angiotensin-11 receptor 
antagonists and statins. Oral hypoglycaemic agents (OHA) other than Metformin, e.g. 
Glibenclamide will need to be replaced with either Metformin or insulin  
Review weight management/reduction plan  
Determine rubella status 
(Diabetes UK, 2006; Diabetes UK 2011; NICE 2008). 
 
Ideally, women with T2DM should be referred to see the MDT to discuss pregnancy 
information and a realistic plan made about when to advice women to stop using 
contraception. Women with an HbA1c above 10% should be strongly advised to avoid 
pregnancy (NICE 2008). 
 
Complications of diabetes during pregnancy 
Pregnancies complicated by diabetes are considered ‘high risk’ pregnancies (Table 2). 
Pregnant women aged over 35 years and those with pre-existing medical conditions 
including hypertension and T2DM have greater risk of cardiovascular disease therefore 
monitoring with electrocardiograph (ECG) is recommended (CEMACH (2007). Furthermore, 
as women with T2DM have increased risk of hypertensive disorders in pregnancy and low 
dose aspirin is known to protect individuals with diabetes against hypertension (Diabetes 
UK, 2009), one 75 milligram tablet of aspirin is recommended daily from 12 weeks gestation 
until the birth of the baby. 
 
  
Table 2. Complications of pregnancy associated with different types of diabetes 
Complication Type of DM 
Maternal Ketoacidosis and hypoglycaemia Type 1&2 
Miscarriage Type 1&2 
Genetic malformation Type 1&2 
Still birth/Fetal death Type 1&2, GDM 
Polyhydramnios Type 1&2, GDM 
Pre-eclampsia Type 1&2 
Macrosomia/Large for gestational age Type 1&2, GDM 
Shoulder dystocia/Birth trauma Type 1&2, GDM 
Neonatal hypoglycaemia Type 1&2, GDM 
Induction of labour or caesarean section Type 1&2, GDM 
Transient neonatal morbidity  Type 1&2, GDM 
Obesity and/or diabetes developing later in the baby’s life Type 2, GDM 
(NICE, 2008). 
 
CEMACH (2007) found that pregnancy outcomes were equally poor in women with T2DM as 
those with type T1DM, and poor glycaemic control based on HbA1C results in early 
pregnancy was the most significant risk factor for both congenital malformations and 
stillbirth. 
 
Pregnant women with T2DM are more likely to be older, multiparous and live in deprived 
areas. They are more likely to be obese (BMI ≥ 30 kg/m2), with 62% of those with T2DM 
being classed as obese compared to 15% with T1DM (p<0.001) (CEMACH, 2005) and are 
more at risk of hypertension during pregnancy (Diabetes UK, 2008). Certain ethnic groups 
are also more likely to develop T2DM, particularly people of African, black Caribbean, South 
Asian, Middle Eastern and Chinese family origin (NICE, 2008). Therefore, women and 
families may have socio-economic and cultural influences in addition to diabetes and 
pregnancy to contend with. 
 
Achieving good glycaemic control 
NICE (2008) provides detailed information regarding specific care for pregnant women with 
diabetes, highlighting assessments and information that should be provided at each 
appointment to ensure optimal glycaemic control is achieved. To summarise, women with 
T2DM will require individualised advice regarding blood glucose targets and monitoring. 
Moreover, additional education regarding insulin management may be needed, as many will 
be commencing insulin for the first time and insulin doses change throughout pregnancy 
(Rayburn et al 1985). Women taking insulin will require detailed advice regarding preventing 
and managing hypoglycaemia, plus detecting and managing ketoacidosis. Both conditions 
can be more prevalent in pregnancy and can occur with less warning because of metabolic 
changes in pregnancy (Rayburn et al 1986). 
 
Access to a specialist dietitian is essential to help women achieve the optimum healthy diet 
for diabetes in pregnancy, especially if new to insulin treatment. Women will require 
education to identify sources of dietary carbohydrate, amount of carbohydrate and an 
awareness of glycaemic index. Pregnant women also require advice regarding food hygiene 
and foods contraindicated in pregnancy as part of their routine antenatal care (see NHS 
2011a; NHS 2011b for details). Specialist dietetic advice can also help if women have 
additional challenges such as overweight/obesity; hypoglycaemia or severe nausea/vomiting 
during pregnancy. All women with T2DM can benefit from a dietetic review particularly if they 
haven’t seen a dietitian before or for some time and their T2DM dietary information is 
outdated. 
 
Antenatal Care 
Diabetes is the most frequent medical disorder that affects the outcome of pregnancy. NICE 
(2008) provides very detailed guidance regarding antenatal care for women with diabetes 
highlighting assessments and information that should be provided at each antenatal 
appointment (Table 3). Women with T2DM will require individualised advice regarding blood 
glucose monitoring and alterations to both diet and medication in order to achieve optimal 
targets throughout pregnancy. The aim of the MDT during pregnancy is to optimise 
pregnancy outcome for women with pre-existing diabetes. Therefore, the importance of the 
health-care relationships for pregnant women with T2DM is crucial and this relationship must 
be open and trusting with the MDT. The aim of antenatal care is not only to provide a 
medically orientated pathway to optimise pregnancy outcomes but also to provide supportive 
midwifery care to assist women with pregnancies complicated with diabetes to achieve the 
best possible emotional health and wellbeing during pregnancy and the transition to 
motherhood.  
 
Antenatal care should be accessed as soon as pregnancy is confirmed as poor pregnancy 
outcome is more prevalent with T2DM. Therefore additional monitoring and screening of 
fetal development is essential, including routine care as well as the specialist involvement of 
the midwife as part of the MDT. Ultrasound scans are used to monitor fetal growth, fetal 
wellbeing (uteroplacental and umbilical artery doppler) and amniotic fluid volume (NICE, 
2008). CEMACH (2007) found that nearly half of babies with macrosomia did not receive 
adequate fetal surveillance; this was associated with fetal and neonatal death. Moreover, 
due to an increased risk of stillbirth, tests for fetal wellbeing in T2DM, such as 
cardiotocographic (CTG) monitoring can be used after 28 weeks gestation when necessary 
(polyhydramnios, accelerated growth or risk of intrauterine growth restriction (IUGR)) and all 
women need detailed advice regarding monitoring of fetal movements (Royal College of 
Obstetricians and Gynaecologists (RCOG), 2011). 
Table 3: Antenatal Care Pathway 
1st Antenatal booking  
visit  
(as soon as 
pregnancy confirmed) 
Medical review with diabetes physician and obstetrician 
Retinal screening in previous 12 months 
Renal assessment with MSSU/proteinuria 
Review/stop/alter medication 
Routine booking bloods for pregnancy to include: U/E’s, TFT’s, 
HbA1c, ACR 
7–9 weeks gestation Ultrasound scan for dating  
Pre-conceptually or 
as soon as pregnancy 
confirmed and until > 
12 weeks gestation 
5 mg Folic Acid 
From 12 weeks 
gestation and 
throughout pregnancy 
75 mg Aspirin (unless contraindicated) 
 
Antenatal visits 
weekly or fortnightly 
depending on 
glycaemic control 
Set individual targets for self-monitoring 
Test fasting (before breakfast), pre-breakfast, pre-lunch, pre-tea & 
bedtime. 
Fasting < 5mmol/l; Pre-meal 3.5 – 5.9 mmol/l; Post-prandial < 7.8 
mmol/l; Bedtime 3.5 – 5.9 mmol/l 
HbA1c  4 weekly 
Pregnancy 
Ultrasound  
10–13 weeks 
 
 
Combined test for Down’s screening  
20 weeks Fetal anatomy (to include cardiac 4-chamber view and outflow 
tracts)  
30 & 34 weeks Growth scans & dopplers  
Scans planned individually if there is a risk of intra uterine growth 
restriction due to maternal comorbidity 
34 weeks Decision about mode of delivery and timing of birth after 34 week 
scan or before if indicated.  
Plan for induction of labour/caesarean section at 38 weeks  
Midwifery advice Women are advised if treated with oral hypoglycaemic agents 
(OHA) before pregnancy to resume pre-pregnancy dose after 
delivery. Only Metformin and Glibenclamide are recommended 
during breastfeeding. Other OHA/medication discontinued during 
pregnancy should be avoided while breastfeeding 
(NICE 2008) 
 
In 2013 Diabetes UK published ‘The State of the Nation’ report and although there were no 
specific data relating to pregnancy, it highlighted inconsistencies regarding quality of care.  
Only 4.2% of people with diabetes were offered structured education with people living in the 
best performing Clinical Commissioning Group areas four times more likely to be given eight 
of the essential health checks recommended by NICE, compared to people living in the 
worst performing area (Diabetes UK 2013). This highlights the need for urgent improvements 
in diabetes care. 
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